Chloroquine and hydroxychloroquine for prevention of COVID‐19: evidence review of clinical benefits and harm

Simple item page
dc.contributor.authorBlockman, M.
dc.contributor.authorCohen, K.
dc.contributor.authorDe Waal, R.
dc.contributor.authorGray, A.
dc.contributor.authorKredo, T.
dc.contributor.authorMaartens, G.
dc.contributor.authorNel, J.
dc.contributor.authorParrish, A.
dc.contributor.authorRees, H.
dc.contributor.departmentSD and TK (Cochrane South Africa, South  African Medical Research Council, SA GRADE Network), MB (Division of Clinical Pharmacology, Department of Medicine,  Groote Schuur Hospital, University of Cape Town)en_US
dc.date.accessioned2020-07-20T09:01:00Z
dc.date.available2020-07-20T09:01:00Z
dc.date.epub2020-06-18
dc.date.issued2020-06-18
dc.identifier.citationBoulware DR, Pullen MF,  Bangdiwala AS, Pastick KA,  Lofgren SM, Okafor EC, et  al. A Randomized Trial of  Hydroxychloroquine as  Postexposure Prophylaxis  for Covid‐19. New England  Journal of Medicine. 2020.en_US
dc.identifier.urihttps://infospace.mrc.ac.za/handle/11288/595264
dc.language.isoenen_US
dc.publisherSouth African National Department of Healthen_US
dc.research.unitSouth African Cochrane Centreen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleChloroquine and hydroxychloroquine for prevention of COVID‐19: evidence review of clinical benefits and harmen_US
dc.typeOtheren_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Blockman M_2020_Chloroquine prophylaxis.pdf
Size:
324.05 KB
Format:
Adobe Portable Document Format
Description:
Thumbnail Image
Name: Blockman M_2020_Chloroquine prophylaxis.pdf
Size: 324.05 KB
Kind: Adobe PDF
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Name: license.txt
Size: 1.71 KB
Kind: License
Collections
Intramural: Journal Articles